|
Status |
Public on Apr 09, 2018 |
Title |
HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter |
Organism |
Mycobacterium tuberculosis |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
The purpose of this study was to characterize the mechanism of action of the small molecule HC2091
|
|
|
Overall design |
Mtb strain CDC1551 was grown at 37ºC in T-25 vented, standing tissue culture flasks in 8 mL of buffered 7H9 medium to an OD600 of 0.1. Cultures were subsequently treated with 10 µM HC2091 ro SQ109. For the control, cultures treated with an equal amount of DMSO. Following a 24 h incubation period, total bacterial RNA was extracted, quality controlled and sequenced. Each treatment was repeated with two independent (biological) replicates.
|
|
|
Contributor(s) |
Zheng H, Williams JT, Coulson GB, Haiderer ER, Abramovitch RB |
Citation(s) |
29661875 |
|
Submission date |
Nov 29, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Robert B. Abramovitch |
Organization name |
Michigan State University
|
Department |
Microbiology and Molecular Genetics
|
Street address |
567 Wilson Road
|
City |
East Lansing |
State/province |
MI |
ZIP/Postal code |
48824 |
Country |
USA |
|
|
Platforms (1) |
GPL17879 |
Illumina HiSeq 2500 (Mycobacterium tuberculosis) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA420343 |
SRA |
SRP125816 |